GH1 and neoplasm: Somatostatin (SST), a growth hormone (GH)-inhibitory peptide, inhibits tumour cell proliferation and induces the prompt shrinkage of most tumours via binding to five different receptor subtypes that play an important role in a wide range of tumour treatment.